Biotech News
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement
ir.cyclerion.com2026-05-06 15:20 EST
CAMBRIDGE, Mass. , June 01, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (“Cyclerion” or the “Company”) (Nasdaq: CYCN) today announced that it has received a formal notice from The Nasdaq Stock Market (Nasdaq) stating that Cyclerion has regained compliance with the $1.00 per share minimum